Emma S. Luckett

554 total citations
15 papers, 208 citations indexed

About

Emma S. Luckett is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Emma S. Luckett has authored 15 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 11 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Emma S. Luckett's work include Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (11 papers) and Genetic Associations and Epidemiology (2 papers). Emma S. Luckett is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (11 papers) and Genetic Associations and Epidemiology (2 papers). Emma S. Luckett collaborates with scholars based in Belgium, United States and Netherlands. Emma S. Luckett's co-authors include Rik Vandenberghe, Jolien Schaeverbeke, Steffi De Meyer, Patrick Dupont, Koen Van Laere, Koen Poesen, Silvy Gabel, Katarzyna Adamczuk, Charlotte E. Teunissen and Erik Stoops and has published in prestigious journals such as PLoS ONE, Brain and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Emma S. Luckett

15 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma S. Luckett Belgium 9 153 121 48 42 27 15 208
Steffi De Meyer Belgium 9 148 1.0× 124 1.0× 58 1.2× 44 1.0× 27 1.0× 17 233
Alexander Jethwa Germany 7 188 1.2× 174 1.4× 50 1.0× 36 0.9× 20 0.7× 11 273
Anna Orduña Dolado Sweden 4 199 1.3× 180 1.5× 49 1.0× 44 1.0× 14 0.5× 6 269
Nesrine Rahmouni Canada 8 190 1.2× 161 1.3× 45 0.9× 41 1.0× 48 1.8× 39 290
Rémy Genthon France 4 135 0.9× 87 0.7× 70 1.5× 49 1.2× 34 1.3× 4 235
Olga Uspenskaya Germany 6 170 1.1× 140 1.2× 48 1.0× 45 1.1× 47 1.7× 9 254
Alícia Nadal Spain 6 171 1.1× 143 1.2× 74 1.5× 31 0.7× 44 1.6× 7 280
Nienke M.E. Scheltens Netherlands 5 105 0.7× 131 1.1× 27 0.6× 30 0.7× 48 1.8× 10 194
Michelle Tegg Australia 4 122 0.8× 97 0.8× 49 1.0× 35 0.8× 13 0.5× 4 207
Guadalupe Fernández‐Villullas Spain 10 135 0.9× 160 1.3× 23 0.5× 55 1.3× 60 2.2× 22 240

Countries citing papers authored by Emma S. Luckett

Since Specialization
Citations

This map shows the geographic impact of Emma S. Luckett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma S. Luckett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma S. Luckett more than expected).

Fields of papers citing papers by Emma S. Luckett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma S. Luckett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma S. Luckett. The network helps show where Emma S. Luckett may publish in the future.

Co-authorship network of co-authors of Emma S. Luckett

This figure shows the co-authorship network connecting the top 25 collaborators of Emma S. Luckett. A scholar is included among the top collaborators of Emma S. Luckett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma S. Luckett. Emma S. Luckett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Luckett, Emma S., Luigi Lorenzini, David Vállez García, et al.. (2025). Harmonizing genotype array data to understand genetic risk for brain amyloid burden in the AMYPAD PNHS Consortium. Alzheimer s & Dementia. 21(9). e70376–e70376. 1 indexed citations
2.
Meyer, Steffi De, Jolien Schaeverbeke, Emma S. Luckett, et al.. (2024). Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET. Brain Communications. 6(4). fcae162–fcae162. 9 indexed citations
3.
Meyer, Steffi De, Jolien Schaeverbeke, Mariska Reinartz, et al.. (2023). Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes. Brain. 147(3). 936–948. 19 indexed citations
4.
Luckett, Emma S., Jolien Schaeverbeke, Katarzyna Adamczuk, et al.. (2023). Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults. Alzheimer s Research & Therapy. 15(1). 121–121. 10 indexed citations
5.
Meyer, Steffi De, Jolien Schaeverbeke, Mariska Reinartz, et al.. (2023). Serum biomarkers for prognosis and monitoring in asymptomatic Alzheimer’s Disease. Alzheimer s & Dementia. 19(S14). 1 indexed citations
6.
Chatterjee, Shreyasi, Megan Sealey, Keeley J. Brookes, et al.. (2023). Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration. PLoS ONE. 18(1). e0262792–e0262792. 13 indexed citations
7.
Luckett, Emma S., Jolien Schaeverbeke, Steffi De Meyer, et al.. (2023). Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations. NeuroImage Clinical. 37. 103321–103321. 3 indexed citations
8.
Reinartz, Mariska, Emma S. Luckett, Jolien Schaeverbeke, et al.. (2022). Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth. European Journal of Nuclear Medicine and Molecular Imaging. 49(11). 3772–3786. 6 indexed citations
9.
Luckett, Emma S., Mariska Reinartz, Katarzyna Adamczuk, et al.. (2022). Association of Alzheimer’s disease polygenic risk scores with amyloid accumulation in cognitively intact older adults. Alzheimer s Research & Therapy. 14(1). 138–138. 9 indexed citations
10.
Meyer, Steffi De, Jeroen Vanbrabant, Jolien Schaeverbeke, et al.. (2022). Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease. Annals of Clinical and Translational Neurology. 9(5). 734–746. 22 indexed citations
11.
Schaeverbeke, Jolien, Emma S. Luckett, Silvy Gabel, et al.. (2022). Lack of association between bridging integrator 1 ( BIN1 ) rs744373 polymorphism and tau‐PET load in cognitively intact older adults. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12227–e12227. 3 indexed citations
12.
Reinartz, Mariska, Silvy Gabel, Jolien Schaeverbeke, et al.. (2021). Changes in the language system as amyloid-β accumulates. Brain. 144(12). 3756–3768. 13 indexed citations
13.
Schaeverbeke, Jolien, Silvy Gabel, Karen Meersmans, et al.. (2021). Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults. Alzheimer s Research & Therapy. 13(1). 75–75. 28 indexed citations
14.
Meyer, Steffi De, Jolien Schaeverbeke, Inge M.W. Verberk, et al.. (2020). Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis. Alzheimer s Research & Therapy. 12(1). 162–162. 70 indexed citations
15.
Schaeverbeke, Jolien, Benjamin Gille, Inge M.W. Verberk, et al.. (2020). Comparison of two analytical platforms for blood‐based surrogate biomarkers of amyloid pathology. Alzheimer s & Dementia. 16(S4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026